Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2219392120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Abdelahhad Barbour und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1G6, Canada. Hauptthemen laut MEDLINE: Bacteriocins. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gouvernement du Canada | Canadian Institutes of Health Research, John Evans Leadership funds, Mitacs.
Abstract (Originalsprache)
Lantibiotics are ribosomally synthesized and posttranslationally modified peptides (RiPPs) that are produced by bacteria. Interest in this group of natural products is increasing rapidly as alternatives to conventional antibiotics. Some human microbiome–derived commensals produce lantibiotics to impair pathogens’ colonization and promote healthy microbiomes. Streptococcus salivarius is one of the first commensal microbes to colonize the human oral cavity and gastrointestinal tract, and its biosynthesis of RiPPs, called salivaricins, has been shown to inhibit the growth of oral pathogens. Herein, we report on a phosphorylated class of three related RiPPs, collectively referred to as salivaricin 10, that exhibit proimmune activity and targeted antimicrobial properties against known oral pathogens and multispecies biofilms. Strikingly, the immunomodulatory activities observed include upregulation of neutrophil-mediated phagocytosis, promotion of antiinflammatory M2 macrophage polarization, and stimulation of neutrophil chemotaxis—these activities have been attributed to the phosphorylation site identified on the N-terminal region of the peptides. Salivaricin 10 peptides were determined to be produced by S. salivarius strains found in healthy human subjects, and their dual bactericidal/antibiofilm and immunoregulatory activity may provide new means to effectively target infectious pathogens while maintaining important oral microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1G6, Canada.
- Department of Biology, College of Science, Texas A&M University, College Station, TX 77843.
- Laboratory of Tissue Repair and Regeneration, Keenan Research Centre for Biomedical Science of the St. Michael's Hospital, Toronto, ON M5B 1T8, Canada.
- Sano Chemicals Inc, Bryan, TX 77803.
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030.
- Texas Children's Microbiome Center, Texas Children's Hospital, Houston, TX 77030.
ORCID-Profile: Abdelahhad Barbour, McKinley Williams, Cara Marks, Chunxiang Sun, Sina Zargaran, Thomas D Horvath, Anthony M Haag, Amarpreet Sabharwal, Boris Hinz, Michael Glogauer
Förderung
- Gouvernement du Canada | Canadian Institutes of Health Research
- John Evans Leadership funds
- Mitacs
- Canada Foundation for Innovation
Zitieren
APA
Barbour, A., Smith, L., Oveisi, M., Williams, M., Huang, R. C., Marks, C., Fine, N., Sun, C., Younesi, F., Zargaran, S., Orugunty, R., Horvath, T. D., Haidacher, S. J., Haag, A. M., Sabharwal, A., Hinz, B., & Glogauer, M. (2023). Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2219392120
Vancouver
Barbour A, Smith L, Oveisi M, Williams M, Huang RC, Marks C, et al. Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2219392120
BibTeX
@article{Barbour2023,
author = {Barbour, Abdelahhad and Smith, Leif and Oveisi, Morvarid and Williams, McKinley and Huang, Ruo Chen and Marks, Cara and Fine, Noah and Sun, Chunxiang and Younesi, Fereshteh and Zargaran, Sina and Orugunty, Ravi and Horvath, Thomas D and Haidacher, Sigmund J and Haag, Anthony M and Sabharwal, Amarpreet and Hinz, Boris and Glogauer, Michael},
title = {Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2219392120}
}
EUVIMED